Details

Subject(s)

• Drugs—Handbooks, manuals, etc [Browse]
• Palliative treatment—Handbooks, manuals, etc [Browse]

Series

Oxford medical publications. [More in this series]

Summary note

While palliative care has adopted a holistic approach to treatment, medication driven symptom management ostensibly forms the critical aspect of care. Pharmacological therapy can be extremely complex because these patients often have co-existing medical conditions in addition to symptoms caused by their terminal disease. The resulting polypharmacy can be daunting for professionals and can negatively impact on effectiveness of care.The practitioner requires a simple, easy to navigate reference source that provides succinct and pertinent drug information. This detailed yet concise handbook will

Notes

Includes index.

Language note

English

Contents

• Contents; Symbols and abbreviations; 1 Clinical pharmacology overview; Introduction; Pharmacokinetics; Pharmacodynamics; Pharmacogenetics; Drug interactions; 2 Prescribing guidance; Unlicensed use of medicines; Legal categories of medicines; Independent prescribing: palliative care issues; Travelling abroad with medicines; Management of pain; Management of pain: selection of an NSAID; Management of pain: opioid substitution; Management of pain: breakthrough cancer pain (BTcP); Management of pain: neuropathic pain; Management of pain: poorly controlled pain; Management of nausea and vomiting
• Management of constipationDiscontinuing and/or switching antidepressants; Continuous subcutaneous infusions; Use of drugs in end-of-life care; 3 Drug monographs A-Z; Monographs; Alfentanil; Allopurinol; Amitriptyline; Amoxicillin; Anastrozole; Baclofen; Betahistine; Bicalutamide; Bisacodyl; Bisoprolol; Buprenorphine; Carbamazepine; Carbocisteine; Celecoxib; Ciprofloxacin; Citalopram; Clonazepam; Co-danthramer; Codeine; Cyclizine; Cyproheptadine; Cyproterone; Dalteparin; Demeclocycline; Dexamethasone; Diamorphine; Diazepam; Diclofenac; Diethylstilbestrol; Dihydrocodeine; Docusate sodium
• DomperidoneDonepezil; Duloxetine; Enoxaparin; Erlotinib; Erythromycin; Esomeprazole; Etamsylate; Etoricoxib; Exemestane; Fentanyl; Finasteride; Flucloxacillin; Fluconazole; Flumazenil; Fluoxetine; Flutamide; Furosemide; Gabapentin; Gliclazide; Glimepiride; Glipizide; Glyceryl trinitrate (GTN); Glycopyrronium; Granisetron; Haloperidol; Hydromorphone; Hyoscine butylbromide; Hyoscine hydrobromide; Ibuprofen; Imatinib; Insulin: biphasic insulin aspart; Insulin: biphasic insulin lispro; Insulin: biphasic isophane insulin; Insulin: insulin aspart; Insulin: insulin detemir; Insulin: insulin glargine
• Insulin: insulin lisproInsulin: isophane insulin; Insulin: soluble; Ipratropium bromide; Ketamine; Ketorolac; Lactulose; Lansoprazole; Letrozole; Levomepromazine; Lidocaine; Loperamide; Lorazepam; Macrogol '3350'; Magnesium hydroxide; Magnesium-L-aspartate; Magnesium sulphate; Medroxyprogesterone; Megestrol; Metformin; Methadone; Methylnaltrexone; Methylphenidate; Metoclopramide; Metronidazole; Midazolam; Mirtazapine; Misoprostol; Modafinil; Morphine; Nabumetone; Naloxone; Naproxen; Nifedipine; Nitrofurantoin; Nystatin; Octreotide; Olanzapine; Omeprazole; Ondansetron; Oxybutynin; Oxycodone
• Pamidronate disodiumPantoprazole; Paracetamol; Paroxetine; Phenobarbital; Pramipexole; Prednisolone; Pregabalin; Propantheline; Quinine sulphate; Rabeprazole; Ranitidine; Reboxetine; Repaglinide; Risperidone; Ropinirole; Rosiglitazone; Salbutamol; Salmeterol; Senna (sennosides); Sertraline; Sevelamer; Spironolactone; Sucralfate; Tamoxifen; Tamsulosin; Temazepam; Thalidomide; Theophylline; Tiotropium; Tolterodine; Tramadol; Tranexamic acid; Trazodone; Trimethoprim; Venlafaxine; Warfarin; Zoledronic acid; Zolpidem; Zopiclone; Index; A; B; C; D; E; F; G; H; I; J; K; L; M; N; O; P; Q; R; S; T; U
• V

Show 3 more Contents items

ISBN

• 1-283-58173-6
• 9786613894182
• 0-19-157589-5

OCLC

801363633

Statement on responsible collection description

Princeton University Library aims to describe library materials in a manner that is respectful to the individuals and communities who create, use, and are represented in the collections we manage. Read more...